(Q44182656)

30 November 2017

title

Aberrant signaling of TGF-beta1 by the mutant Smad4 in gastric cancer cells (English)

1 reference

30 November 2017

Hyang Ran Ju

1

1 reference

30 November 2017

Uhee Jung

2

1 reference

30 November 2017

Chung Hee Sonn

3

1 reference

30 November 2017

Suk Ran Yoon

4

1 reference

30 November 2017

Jun Ho Jeon

5

1 reference

30 November 2017

Young Yang

6

1 reference

30 November 2017

Kee Nyung Lee

7

1 reference

30 November 2017

Inpyo Choi

8

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

30 November 2017

1 reference

30 November 2017

volume

196

1 reference

30 November 2017

issue

2

1 reference

30 November 2017

page(s)

197-206

1 reference

TGF-beta signaling in tumor suppression and cancer progression

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900237-4

7 January 2021

TGFbeta signaling in growth control, cancer, and heritable disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900237-4

7 January 2021

How cells read TGF-beta signals

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900237-4

7 January 2021

TGF-beta signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900237-4

7 January 2021

Cross-talk between the p42/p44 MAP kinase and Smad pathways in transforming growth factor beta 1-induced furin gene transactivation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900237-4

7 January 2021

Requirement of Ras/MAPK pathway activation by transforming growth factor beta for transforming growth factor beta 1 production in a Smad-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900237-4

7 January 2021

Sequence-specific enhancer binding protein is responsible for the differential expression of ERT/ESX/ELF-3/ESE-1/jen gene in human gastric cancer cell lines: Implication for the loss of TGF-beta type II receptor expression

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900237-4

7 January 2021

Truncation of the TGF-beta type II receptor gene results in insensitivity to TGF-beta in human gastric cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900237-4

7 January 2021

Mutations of the transforming growth factor-beta type II receptor gene are strongly related to sporadic proximal colon carcinomas with microsatellite instability.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900237-4

7 January 2021

Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900237-4

7 January 2021

Functional consequences of tumorigenic missense mutations in the amino-terminal domain of Smad4

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900237-4

7 January 2021

Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900237-4

7 January 2021

TGF-beta/SMAD signaling and its involvement in tumor progression.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900237-4

7 January 2021

Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900237-4

7 January 2021

Rapid induction of p21WAF1 but delayed down-regulation of Cdc25A in the TGF-beta-induced cell cycle arrest of gastric carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900237-4

7 January 2021

Role of TGF-beta in immune-evasion of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900237-4

7 January 2021

Mutations in the SMAD4/DPC4 gene in juvenile polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900237-4

7 January 2021

A Smad transcriptional corepressor

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900237-4

7 January 2021

Transforming Growth Factor-beta Receptors: Role in Physiology and Disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900237-4

7 January 2021

TGFbeta1 represses proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900237-4

7 January 2021

Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900237-4

7 January 2021

Regulation of Smad signaling by protein kinase C

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900237-4

7 January 2021

Transforming growth factor-beta and breast cancer: Transforming growth factor-beta/SMAD signaling defects and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900237-4

7 January 2021

10.1016/S0304-3835(03)00237-4

Identifiers

DOI

1 reference

30 November 2017

1 reference